BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,188,274 | -16.7% | 86,685 | +1.3% | 0.01% | -16.7% |
| Q2 2023 | $3,825,189 | -23.6% | 85,613 | -30.7% | 0.01% | -25.0% |
| Q1 2023 | $5,009,647 | -36.1% | 123,512 | -19.7% | 0.01% | -38.5% |
| Q4 2022 | $7,842,703 | -1.3% | 153,869 | +4.4% | 0.01% | -7.1% |
| Q3 2022 | $7,942,000 | -12.1% | 147,453 | +4.8% | 0.01% | 0.0% |
| Q2 2022 | $9,038,000 | -4.7% | 140,713 | +15.0% | 0.01% | +7.7% |
| Q1 2022 | $9,484,000 | -3.2% | 122,308 | +7.2% | 0.01% | 0.0% |
| Q4 2021 | $9,797,000 | +8.0% | 114,135 | +1.2% | 0.01% | 0.0% |
| Q3 2021 | $9,075,000 | -2.1% | 112,837 | -2.0% | 0.01% | 0.0% |
| Q2 2021 | $9,272,000 | -49.3% | 115,180 | -46.9% | 0.01% | -53.6% |
| Q1 2021 | $18,300,000 | +21.2% | 216,973 | +15.3% | 0.03% | -15.2% |
| Q4 2020 | $15,099,000 | -94.8% | 188,179 | -94.8% | 0.03% | -95.5% |
| Q3 2020 | $292,182,000 | -1.2% | 3,633,199 | +5.7% | 0.73% | -8.3% |
| Q2 2020 | $295,826,000 | +23.6% | 3,435,838 | +16.6% | 0.79% | +3.0% |
| Q1 2020 | $239,252,000 | -20.1% | 2,946,812 | -17.7% | 0.77% | +4.8% |
| Q4 2019 | $299,253,000 | +11.7% | 3,578,730 | +16.8% | 0.73% | +4.3% |
| Q3 2019 | $268,008,000 | -2.0% | 3,064,001 | -8.2% | 0.70% | -0.1% |
| Q2 2019 | $273,361,000 | +0.8% | 3,337,744 | +0.1% | 0.70% | +7.8% |
| Q1 2019 | $271,207,000 | +25.1% | 3,335,475 | +1.3% | 0.65% | +14.7% |
| Q4 2018 | $216,810,000 | +3.2% | 3,293,987 | +20.8% | 0.57% | +11.5% |
| Q3 2018 | $210,170,000 | +9.3% | 2,726,299 | +4.7% | 0.51% | +4.1% |
| Q2 2018 | $192,318,000 | +470.8% | 2,604,528 | +402.8% | 0.49% | +470.9% |
| Q1 2018 | $33,691,000 | +116.5% | 518,001 | +115.1% | 0.09% | +126.3% |
| Q4 2017 | $15,565,000 | +14.7% | 240,792 | +11.3% | 0.04% | -47.9% |
| Q3 2017 | $13,570,000 | +86.6% | 216,258 | +80.1% | 0.07% | +82.5% |
| Q2 2017 | $7,271,000 | +37.0% | 120,096 | +17.3% | 0.04% | +29.0% |
| Q1 2017 | $5,308,000 | +442.7% | 102,352 | +363.9% | 0.03% | +416.7% |
| Q4 2016 | $978,000 | -5.0% | 22,062 | +2.0% | 0.01% | 0.0% |
| Q3 2016 | $1,030,000 | -97.6% | 21,636 | -97.7% | 0.01% | -97.5% |
| Q2 2016 | $42,665,000 | +11.7% | 943,491 | +1.5% | 0.24% | -30.3% |
| Q1 2016 | $38,193,000 | +10.7% | 929,721 | +2.8% | 0.35% | +61.7% |
| Q4 2015 | $34,513,000 | +6.8% | 904,671 | -8.0% | 0.21% | +9.2% |
| Q3 2015 | $32,304,000 | -23.9% | 983,372 | -12.0% | 0.20% | -14.8% |
| Q2 2015 | $42,432,000 | -44.4% | 1,116,919 | +0.3% | 0.23% | -42.8% |
| Q1 2015 | $76,265,000 | -1.1% | 1,113,360 | +5.8% | 0.40% | +2.3% |
| Q4 2014 | $77,089,000 | -3.4% | 1,051,837 | -5.4% | 0.39% | -1.8% |
| Q3 2014 | $79,810,000 | -2.9% | 1,112,031 | -2.2% | 0.40% | +4.7% |
| Q2 2014 | $82,185,000 | +37.2% | 1,136,716 | +39.6% | 0.38% | +29.9% |
| Q1 2014 | $59,904,000 | +35.8% | 814,140 | +28.3% | 0.29% | +31.8% |
| Q4 2013 | $44,125,000 | +4696.2% | 634,429 | +4431.6% | 0.22% | +4360.0% |
| Q3 2013 | $920,000 | -63.6% | 14,000 | -61.6% | 0.01% | -58.3% |
| Q2 2013 | $2,528,000 | – | 36,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |